Latest Press Releases
View all
TimeHeadline
16m agoTimberland Bancorp Reports Second Fiscal Quarter Net Income of $7.1 Million
42m agoCPKC increases dividend by 17.5 percent
42m agoWaldencast announces conclusion of SEC investigation
43m agoNektar to Announce Financial Results for the First Quarter on Thursday, May 7, 2026, After Close of U.S.-Based Financial Markets
43m agoF5 to Host Analyst and Investor Meeting on May 28, 2026
Annovis Bio Inc logo

Annovis Bio Inc

About

Annovis Bio Inc (NYSE:ANVS) — investor relations, events, news, and company updates on 6ix.

Latest News

Today
Annovis Publishes Phase 2/3 Alzheimer's Trial Results in Nature Portfolio
Apr 10 2026
Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer's Disease 6-Month NDA Submission
Apr 9 2026
Annovis Announces $10 Million Underwritten Offering of Common Stock and Accompanying Warrants
Apr 2 2026
Annovis Secures U.S. Patent for Buntanetap in the Prevention and Treatment of Neurological Injuries Caused by Brain Infections
Mar 31 2026
Annovis Publishes Historical Review of Buntanetap in The Scientist

Financials

Revenue
$0
Market Cap
$64.65 M
EPS
-1.40

Community Chat

Ask AI

6ix6ixAIEvents